Discovery of Anti-PD-L1 Human Domain Antibodies for Cancer Immunotherapy

Overview of attention for article published in Frontiers in immunology, April 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter: 5 X users

patent: 2 patents

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 11 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

FUSION POLYPEPTIDE COMPRISING AN ANTI-PD-L1 SDAB AND A MEMBER OF THE TNFSF

Application WO-2023213764-A1

World Intellectual Property Organisation (WIPO)

POXVIRUS ENCODING A BINDING AGENT COMPRISING AN ANTI- PD-L1 SDAB

Application WO-2023213763-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.